药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Etidronic acid
Glatiramer
The risk or severity of adverse effects can be increased when Aldosterone is combined with Glatiramer.
Etidronic acid
Interferon alfa
The risk or severity of adverse effects can be increased when Aldosterone is combined with Interferon alfa.
Etidronic acid
Trabectedin
The risk or severity of adverse effects can be increased when Aldosterone is combined with Trabectedin.
Etidronic acid
Belinostat
The risk or severity of adverse effects can be increased when Aldosterone is combined with Belinostat.
Etidronic acid
Pirfenidone
The risk or severity of adverse effects can be increased when Aldosterone is combined with Pirfenidone.
Etidronic acid
Brequinar
The risk or severity of adverse effects can be increased when Brequinar is combined with Aldosterone.
Etidronic acid
2-Methoxyethanol
The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Aldosterone.
Etidronic acid
Vorinostat
The risk or severity of adverse effects can be increased when Vorinostat is combined with Aldosterone.
Etidronic acid
Castanospermine
The risk or severity of adverse effects can be increased when Castanospermine is combined with Aldosterone.
Etidronic acid
Stepronin
The risk or severity of adverse effects can be increased when Stepronin is combined with Aldosterone.
Etidronic acid
Nelarabine
The risk or severity of adverse effects can be increased when Nelarabine is combined with Aldosterone.
Etidronic acid
Eculizumab
The risk or severity of adverse effects can be increased when Eculizumab is combined with Aldosterone.
Etidronic acid
Lomustine
The risk or severity of adverse effects can be increased when Lomustine is combined with Aldosterone.
Etidronic acid
Ifosfamide
The risk or severity of adverse effects can be increased when Ifosfamide is combined with Aldosterone.
Etidronic acid
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Aldosterone.
Etidronic acid
Capecitabine
The risk or severity of adverse effects can be increased when Capecitabine is combined with Aldosterone.
Etidronic acid
Flucytosine
The risk or severity of adverse effects can be increased when Flucytosine is combined with Aldosterone.
Etidronic acid
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Aldosterone.
Perhexiline
Lonafarnib
The serum concentration of Lonafarnib can be increased when it is combined with Estrone sulfate.
Perhexiline
Somapacitan
The therapeutic efficacy of Somapacitan can be decreased when used in combination with Estrone sulfate.